• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米安色林在抑郁症患者中的药代动力学。

Mianserin kinetics in depressed patients.

作者信息

Hrdina P D, Lapierre Y D, McIntosh B, Oyewumi L K

出版信息

Clin Pharmacol Ther. 1983 Jun;33(6):757-62. doi: 10.1038/clpt.1983.103.

DOI:10.1038/clpt.1983.103
PMID:6851406
Abstract

We studied mianserin kinetics after a single (60 mg) dose in eight inpatients suffering from depression. There was a considerable interpatient variability in plasma levels. Mean peak plasma levels (+/- SEM) were 114 +/- 26 ng/ml and were reached between 1 and 3 hr. The decline of mianserin levels in plasma was biphasic. The mean elimination t 1/2 was 21.6 +/- 3.1 hr and ranged from 10.7 to 40.8 hr. The estimated first-pass loss ranged from 26% to 48% (mean, 37%) and was lower than that reported for tertiary amine tricyclic antidepressants. The mean apparent volume of distribution (15.7 +/- 2.2 l/kg; 9.7 to 28.8 l/kg) was in the range of that for imipramine but somewhat lower than for maprotiline. Apparent total body clearance ranged from 0.33 to 0.81 l/hr/kg (mean +/- SEM, 0.52 +/- 0.05 l/hr/kg) and was of the order of that after maprotiline. Our results indicate that mianserin kinetics are in most respects similar to those of tertiary amine tricyclic antidepressants (e.g., imipramine) and the tetracyclic maprotiline.

摘要

我们对8名抑郁症住院患者单次服用60毫克米安色林后的药代动力学进行了研究。患者之间血浆水平存在相当大的差异。平均血浆峰浓度(±标准误)为114±26纳克/毫升,在1至3小时之间达到。血浆中米安色林水平的下降呈双相性。平均消除半衰期为21.6±3.1小时,范围为10.7至40.8小时。估计的首过损失范围为26%至48%(平均为37%),低于叔胺类三环抗抑郁药的报告值。平均表观分布容积为15.7±2.2升/千克(9.7至28.8升/千克),与丙咪嗪的范围相当,但略低于马普替林。表观全身清除率范围为0.33至0.81升/小时/千克(平均±标准误,0.52±0.05升/小时/千克),与马普替林后的清除率相当。我们的结果表明,米安色林的药代动力学在大多数方面与叔胺类三环抗抑郁药(如丙咪嗪)和四环类马普替林相似。

相似文献

1
Mianserin kinetics in depressed patients.米安色林在抑郁症患者中的药代动力学。
Clin Pharmacol Ther. 1983 Jun;33(6):757-62. doi: 10.1038/clpt.1983.103.
2
Mianserin and maprotiline as compared to amitriptyline in severe endogenous depression. A new methodological approach to the clinical evaluation of the efficacy of antidepressants.米安色林和马普替林与阿米替林治疗重度内源性抑郁症的比较。一种评估抗抑郁药疗效的临床新方法。
Pharmacopsychiatria. 1982 Nov;15(6):197-204. doi: 10.1055/s-2007-1019538.
3
A double-blind trial comparing mianserin and maprotiline in depressed inpatients.一项比较米安色林和马普替林治疗住院抑郁症患者的双盲试验。
Clin Ther. 1985;7(5):584-92.
4
The pharmacokinetics of mianserin in elderly depressed patients.米安色林在老年抑郁症患者中的药代动力学。
Psychiatry Res. 1983 Apr;8(4):281-7. doi: 10.1016/0165-1781(83)90016-1.
5
Mianserin versus maprotiline in patients with a depressive syndrome.米安色林与马普替林治疗抑郁综合征患者的疗效比较
Acta Neurol (Napoli). 1984 Apr;6(2):140-6.
6
Absolute bioavailability of mianserin tablets and solution in healthy humans.米安色林片剂和溶液在健康人体中的绝对生物利用度。
Eur J Drug Metab Pharmacokinet. 1985 Oct-Dec;10(4):315-23. doi: 10.1007/BF03189759.
7
Mianserin, maprotiline and intracardiac conduction.米安色林、马普替林与心内传导
Br J Clin Pharmacol. 1983;15 Suppl 2(Suppl 2):249S-254S. doi: 10.1111/j.1365-2125.1983.tb05872.x.
8
Placebo-controlled trial of mianserin and maprotiline in primary depressive illness: a preliminary report.米安色林与马普替林治疗原发性抑郁症的安慰剂对照试验:初步报告。
Br J Clin Pharmacol. 1983;15 Suppl 2(Suppl 2):239S-248S. doi: 10.1111/j.1365-2125.1983.tb05871.x.
9
The pharmacokinetics of mianserin.米安色林的药代动力学。
Br J Clin Pharmacol. 1983;15 Suppl 2(Suppl 2):313S-322S. doi: 10.1111/j.1365-2125.1983.tb05880.x.
10
Mianserin.米安色林
Mod Probl Pharmacopsychiatry. 1982;18:70-101. doi: 10.1159/000406237.

引用本文的文献

1
Differential effect of cancer on the serum protein binding to mianserin and imipramine.癌症对血清蛋白与米安色林及丙咪嗪结合的差异影响。
Eur J Drug Metab Pharmacokinet. 1995 Apr-Jun;20(2):107-11. doi: 10.1007/BF03226363.
2
Pharmacokinetic optimisation of tricyclic antidepressant therapy.三环类抗抑郁药治疗的药代动力学优化
Clin Pharmacokinet. 1993 Apr;24(4):301-18. doi: 10.2165/00003088-199324040-00004.
3
Absolute bioavailability of mianserin tablets and solution in healthy humans.米安色林片剂和溶液在健康人体中的绝对生物利用度。
Eur J Drug Metab Pharmacokinet. 1985 Oct-Dec;10(4):315-23. doi: 10.1007/BF03189759.
4
Plasma concentrations of mianserin after single dose and at steady-state in depressed elderly patients.老年抑郁症患者单次给药后及稳态时米安色林的血药浓度。
Clin Pharmacokinet. 1987 Jan;12(1):73-8. doi: 10.2165/00003088-198712010-00005.
5
Variability in the elimination of mianserin in elderly patients.老年患者米安色林消除的变异性。
Br J Clin Pharmacol. 1989 Apr;27(4):445-51. doi: 10.1111/j.1365-2125.1989.tb05392.x.